Sotera Health Quarterly Income Statement
NASDAQ: SHCHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sotera Health revenue and earnings
In the quarter ended Jun 30, 2026, Sotera Health generated $321.4 million in revenue, up 9.2% from the same quarter a year earlier. Net income was $53.6 million (+573.7% year over year), for a net margin of 16.7% versus a median of 9.5% in the prior 5 quarters. Gross margin was 55.4% (down from 56.6%).
Diluted earnings per share came in at $0.19, up from $0.03.
Summary generated from market data by MetaCap's automated system. Methodology
Sotera Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.38M | 280.05M | 303.44M | 311.31M | 294.34M | 254.52M | 290.20M | 285.47M | 276.59M | 248.18M | 310.24M | 263.18M |
| Revenue growth (YoY) | +9.18% | +10.03% | +4.56% | +9.05% | +6.42% | +2.56% | -6.46% | +8.47% | +8.35% | +12.51% | +23.31% | +5.82% |
| Cost of Revenue | 143.41M | 132.98M | 137.52M | 133.75M | 127.72M | 119.09M | 125.84M | 127.44M | 123.80M | 121.06M | 130.16M | 117.19M |
| Gross Profit | 177.96M | 147.07M | 165.92M | 177.56M | 166.62M | 135.43M | 164.37M | 158.02M | 152.79M | 127.11M | 180.08M | 145.98M |
| Operating Expenses | — | — | — | — | — | — | 77.22M | 77.52M | 75.99M | 73.94M | 76.06M | 69.89M |
| Selling, General & Admin | 68.16M | 68.21M | 57.51M | 63.29M | 68.89M | 63.06M | 61.84M | 62.01M | 60.58M | 58.21M | 60.36M | 54.11M |
| Operating Income | — | — | — | — | — | — | 87.15M | 80.51M | 76.80M | 53.17M | 104.02M | 76.10M |
| Other Income (Expense) | 2.85M | 960.00K | 2.02M | 464.00K | 5.83M | 241.00K | 1.22M | 2.83M | 1.52M | -961.00K | 4.07M | -427.00K |
| Pretax Income | 78.05M | 42.61M | 70.50M | 72.94M | 18.90M | -14.82M | 44.96M | 42.75M | 15.14M | 11.01M | 65.67M | 470.00K |
| Income Tax | 24.41M | 16.02M | 35.65M | 24.54M | 10.94M | -1.56M | 32.64M | 25.76M | 6.39M | 4.69M | 26.99M | 14.13M |
| Net Income | 53.64M | 26.59M | 34.85M | 48.40M | 7.96M | -13.26M | 12.32M | 17.00M | 8.75M | 6.32M | 38.68M | -13.66M |
| Net Income growth (YoY) | +573.74% | — | +182.78% | +184.74% | -9.05% | -309.71% | -68.14% | — | -62.77% | +122.48% | — | -154.44% |
| EPS (Basic) | 0.19 | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 |
| EPS (Diluted) | 0.19 | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 |
| Shares Outstanding (Basic) | 285.77M | 284.89M | — | 284.07M | 283.93M | 283.56M | — | 283.06M | 282.89M | 281.91M | — | 281.11M |
| Shares Outstanding (Diluted) | 288.15M | 287.62M | — | 286.75M | 285.76M | 283.56M | — | 285.56M | 284.54M | 284.06M | — | 281.11M |
| EBITDA | — | — | — | — | — | — | 107.82M | 103.71M | 96.87M | 73.48M | 124.69M | 94.09M |
| Gross Margin | 55.38% | 52.52% | 54.68% | 57.04% | 56.61% | 53.21% | 56.64% | 55.36% | 55.24% | 51.22% | 58.05% | 55.47% |
| Operating Margin | — | — | — | — | — | — | 30.03% | 28.20% | 27.77% | 21.43% | 33.53% | 28.92% |
| Net Margin | 16.69% | 9.49% | 11.48% | 15.55% | 2.71% | -5.21% | 4.25% | 5.95% | 3.16% | 2.55% | 12.47% | -5.19% |
This table shows 12 quarterly periods of Sotera Health's income statement, from Q2 2026 back to Q3 2023, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SHC's reporting calendar. What is a income statement?